Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Yokose

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Leukemia Research|October 1, 1994
Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromesN Yokose, K Ogata, T Ito, et al.
British Journal of Haematology|May 1, 1995
Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromesK Ogata, H Tamura, N Yokose, et al.
British Journal of Haematology|December 12, 2001
Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemiaK Ogata, N Yokose, Y Shioi, et al.
British Journal of Haematology|December 19, 1998
Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromesH Tamura, K Ogata, S Luo, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Leukemia Research|October 1, 1994
Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromesN Yokose, K Ogata, T Ito, et al.
British Journal of Haematology|May 1, 1995
Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromesK Ogata, H Tamura, N Yokose, et al.
British Journal of Haematology|December 12, 2001
Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemiaK Ogata, N Yokose, Y Shioi, et al.
British Journal of Haematology|December 19, 1998
Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromesH Tamura, K Ogata, S Luo, et al.
Pageof 3